HOME >> BIOLOGY >> NEWS
Electronic nose could spell the end of landfill pongs

Scientists at the University of Manchester have invented a new device which remotely monitors bad odours and methane gases at waste landfill and watertreatment sites.

The device, which works like an electronic nose, could be the solution many communities and waste management companies, who regularly encounter problems with bad odours and air pollution, are searching for.

20.9m tonnes (72%) of household of waste produced in Britain is disposed of in landfill sites. There are currently over 4000 licensed sites in the UK. Eighty per cent of the population live within 2km of a site. Methane gas and odours, which contribute to global warming, are produced by decomposing waste.

Currently there is no other instrumentation sensitive enough to monitor low concentrations of odours and gases on these sites. Gases and odours are analysed manually using handheld detectors and by panels of volunteers asked to smell samples of air.

The new device has four sensors which analyse the composition of gases in the air. Air is sucked into the device at regular intervals and then profiled. The chemical profile of the air is then sent in real-time via a built-in GPS modem to a remote computer. Based on the concentration of various chemicals, the system is able to determine whether the methane gases or odours have reached an unacceptable level. The air is then filtered before being expelled back into the atmosphere.

Professor Krishna Persaud, who has developed the device, said: "Current methods mean odour and gas levels are only monitored on a weekly basis. In that time bad odours can build up. What this device offers is the ability to monitor these levels in real-time, enabling waste companies to act before levels reach an unacceptable level.

"Ultimately, this device has the potential to create a much healthier environment which will benefit both local communities and waste management companies by alerting them to the build up of bad odours a
'"/>

Contact: Simon Hunter
simon.hunter@manchester.ac.uk
161-275-8387
University of Manchester
5-Jan-2006


Page: 1 2

Related biology news :

1. Electronic chip, interacting with the brain, modifies pathways for controlling movement
2. Electronic connectivity isnt all that great, warns computer guru at NJIT talk
3. Electronic records to improve care for children with asthma
4. Electronics recycling made easy
5. Newly created cancer stem cells could aid breast cancer research
6. New system of wastewater treatment could reduce the size of treatment plants by half
7. Discovery of new protein could provide new understanding of male fertility
8. Einstein researchers prototype vaccine could provide improved protection against tuberculosis
9. How a pain in the neck could be bad for your blood pressure
10. Synchrotron could help save the Tassie devil
11. Pets could be source of multiresistant bacteria infections in humans, MU researchers investigate

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Electronic nose could spell the end landfill pongs

(Date:10/15/2014)... the 44th Rosenstiel Award for Distinguished Work in Biomedical ... the mechanisms of genomic instability and its implications for ... second alumnus to win the Rosenstiel Award; the first, ... Alt is the Charles A. Janeway Professor of Pediatrics ... an investigator at the Howard Hughes Medical Institute at ...
(Date:10/14/2014)... shows SIRT6—a protein known to inhibit the growth ... skin cancers by turning on an enzyme that increases ... Previously considered protective, SIRT6 is part of a family ... stability and prevent some of the genetic flaws associated ... lead to cancer. This study, in the journal,s October ...
(Date:10/14/2014)... of the planet,s leading questions is how to produce ... variable climate. The Food and Agriculture Organization of the ... over the next 40 years to feed a growing ... the necessary rise in food production. Plants—grains, cereals, ... supporting livestock. Current research must tap into our ...
Breaking Biology News(10 mins):Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt 2Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer 2Building a bridge from basic botany to applied agriculture 2Building a bridge from basic botany to applied agriculture 3
(Date:10/22/2014)... YORK , Oct. 22, 2014 Nuvilex, ... Federation, approximately 400 million people worldwide are living with ... million people by 2030.  The global market for diabetes ... 2012 approximately 330,000 people worldwide died from pancreatic cancer.  ... death due to cancer in the United ...
(Date:10/22/2014)... and HONG KONG , Oct. ... disease therapeutics enterprise, announced today that rare disease expert ... as vice president, research. Dr. McKew brings more than ... leadership positions at the National Institutes of Health, Wyeth ... by Wyeth). Dr. McKew will lead aTyr,s efforts to expand ...
(Date:10/20/2014)... YORK , Oct. 20, 2014 ... their experimental ZMapp™ antibody therapeutic to fight the ... how difficult and time-consuming the production of pharmaceuticals ... market research publisher said that while some may ... of this compound, those with industry knowledge are ...
(Date:10/20/2014)... , Oct. 20, 2014 Asterias ... the Company has signed a Notice of Grant ... Medicine (CIRM), effective October 1, 2014.  The NGA ... payments and the release of additional grant funds ... grant award for clinical development of Asterias, product, ...
Breaking Biology Technology:Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4
Cached News: